The diversity of potential effects that Artificial intelligence (AI) may have throughout the healthcare spectrum is one of the most intriguing parts of its rise.
The predictive and diagnostic capabilities are at one end of the spectrum and promise to give patients and healthcare professionals a new level of accuracy in identifying ailments and determining the best course of action. On the other end of the spectrum are the tools that are progressively bringing basic services to regions of the world that have long struggled to offer their residents even the most basic of care.
Read How AI And Machine Learning Will Impact The Future Of Healthcare
Four billion people worldwide, or more than half of the world’s population, lack access to basic health care, with those in low- and middle-income nations frequently suffering disproportionately from the adverse affects of this global health crisis. There is less than 1 doctor for every 1,000 people in African nations including Tanzania, Kenya, Somalia, and Mozambique. Tanzania currently has only one doctor per 20,000 patients, according to the World Health Organization. Sierra Leone has three physicians for every 100,000 people. And according to GlobalVoices.org, “ At the peak of COVID-19 in 2020, the Central African Republic, a country of about 5 million people, had just 3 ventilators.”
Afiyasasa Africa LLC wants to significantly increase access to high-quality health information and guidance for people living in rural and urban regions with poor medical infrastructure and few medical experts by using artificial intelligence for healthcare.
Dilan Ellegala, a famous neurosurgeon who recently moved to Tanzania, launched AfiyaSasa Africa, LLC (ASA), a start-up medical technology and virtual health enterprise. Through its platform, it assists individuals in poor nations in obtaining the medical care they require.
The ASA platform utilize the technology developed by AdviNOW, combines artificial intelligence (AI) and augmented reality (AR) to link people who live in rural and urban areas with poor access to healthcare to and few medical professionals both in-country and world-wide.
Patients use their smartphones, tablets, or computers to access the system, which enables licensed doctors and other medical staff to virtually do initial check-in, triage, and choose the best course of care. To determine whether the patient is a returning patient, the system has facial recognition and storing capabilities.
Additionally, measurements can be taken with medical devices that connect to a cell phone, tablet, or computer (such as a stethoscope, thermometer, pulse oximeter, etc.) through a set of questions and answers that are dynamically integrated with the system’s proprietary AI component, taking the telemedicine virtual appointment to the next level and beyond.
AfiyaSasa Africa LLC recently saw the acquisition of a 51% membership interest by Xcelerate Inc., a publicly traded US company.
Xcelerate (Ticker Symbol: XCRT) is a small-cap company publicly listed in USA OTC stock market that has been in operation for a long time but has become very active in the past year. The company has been able to acquire a number of high-quality patents for its proprietary technologies and has signed a number of contracts with major companies.
Read full analysis on XCRT: In the penny stock market, Xcelerate, Inc. (OTC: XCRT) is emerging as a top Healthcare Services stock to watch in 2022.
Under the name of its currently wholly-owned subsidiary, the AfiyaSasa Tanzania Project was launched at 4 hospitals around the country, with each providing a distinct range of services and telehealth capabilities:
Jakaya Kikwete Cardiac Institute, a fifth hospital, has expressed a genuine interest in taking part in the pilot program, therefore a potential program there is currently in the works.
When you consider that Tanzania has a population of close to 60.8 million people, many of whom are in urgent need of medical care, the program’s initial reach would represent a total catchment area of almost 20 million prospective patients.
Once the pilot program has been developed, put to the test, and received widespread approval from both patients and medical professionals, the company will carry out comparable projects at hospitals and outreach clinics all around Tanzania and other nations in Africa.
Xcelerate & Afiyasasa Africa LLC expects its fully operational beta sites to be successful by the end of Q4 2022 and estimates that revenue will start to flow in early 2023.
Disclosure: We disclose that we do not own any shares of XCRT, either long or short, and that we have not received any payment for this article.
Your email address will not be published. Required fields are marked *